NuGen Medical Devices Statistics

Total Valuation

TSXV:NGMD has a market cap or net worth of CAD 13.62 million. The enterprise value is 23.25 million.

Market Cap	13.62M
Enterprise Value	23.25M

Important Dates

The last earnings date was Thursday, June 5, 2025.

Earnings Date	Jun 5, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:NGMD has 227.04 million shares outstanding. The number of shares has increased by 16.67% in one year.

Current Share Class	227.04M
Shares Outstanding	227.04M
Shares Change (YoY)	+16.67%
Shares Change (QoQ)	+3.20%
Owned by Insiders (%)	2.77%
Owned by Institutions (%)	n/a
Float	220.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.62
PB Ratio	-3.22
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.68
EV / Sales	21.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.92

Financial Position

The company has a current ratio of 6.23

Current Ratio	6.23
Quick Ratio	5.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-3.34
Interest Coverage	-2.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-30.66%
Return on Invested Capital (ROIC)	-33.67%
Return on Capital Employed (ROCE)	-41.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	1.72

Taxes

In the past 12 months, TSXV:NGMD has paid 10,624 in taxes.

Income Tax	10,624
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.53% in the last 52 weeks. The beta is 2.23, so TSXV:NGMD's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	-23.53%
50-Day Moving Average	0.06
200-Day Moving Average	0.08
Relative Strength Index (RSI)	44.90
Average Volume (20 Days)	92,586

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:NGMD had revenue of CAD 1.08 million and -1.83 million in losses. Loss per share was -0.01.

Revenue	1.08M
Gross Profit	560,189
Operating Income	-4.51M
Pretax Income	-1.82M
Net Income	-1.83M
EBITDA	-3.89M
EBIT	-4.51M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 6.19 million in cash and 15.82 million in debt, giving a net cash position of -9.63 million or -0.04 per share.

Cash & Cash Equivalents	6.19M
Total Debt	15.82M
Net Cash	-9.63M
Net Cash Per Share	-0.04
Equity (Book Value)	-4.22M
Book Value Per Share	-0.02
Working Capital	5.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.72 million and capital expenditures -10,375, giving a free cash flow of -4.73 million.

Operating Cash Flow	-4.72M
Capital Expenditures	-10,375
Free Cash Flow	-4.73M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 51.90%, with operating and profit margins of -418.16% and -169.90%.

Gross Margin	51.90%
Operating Margin	-418.16%
Pretax Margin	-168.91%
Profit Margin	-169.90%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:NGMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.67%
Shareholder Yield	n/a
Earnings Yield	-13.46%
FCF Yield	-34.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 8, 2021. It was a reverse split with a ratio of 0.5.

Last Split Date	Nov 8, 2021
Split Type	Reverse
Split Ratio	0.5

Scores

TSXV:NGMD has an Altman Z-Score of -3.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.6
Piotroski F-Score	3